Persistent Systems (PERSISTENT) investor relations material

Financial performance and growth trajectory

• Achieved $452.4M in Q1 FY27 revenue, up 16.1% YoY, with a 16.0% EBIT margin and 11.2% PAT margin, both showing double-digit YoY growth.

• Trailing twelve months revenue reached $1,717.1M, reflecting a 16.8% YoY increase.

• Delivered 25 consecutive quarters of sequential revenue growth, significantly outperforming listed Indian IT peers in both QoQ and YoY metrics.

• Maintained strong profitability with EBIT and PAT margins above 11% for FY24-FY26, and revenue CAGR of 17.3% since IPO.

• Demonstrated broad-based momentum across key verticals: BFSI, Healthcare & Life Sciences, and Software & Hi-Tech.

Strategic initiatives and business model evolution

• Transitioned to an AI-led, platform-driven services strategy, focusing on enterprise-wide transformation and outcome-based models.

• Implemented the 3C framework (Core, Context, Coordination) to maximize enterprise ROI from AI investments.

• Built a global workforce of 28,640 employees, with significant talent and delivery presence in India and expanding international footprint.

• Deepened strategic client relationships, increasing the number of $10M+ and $20M+ engagements and expanding the client base to 214 clients with $1M+ revenue.

• Strengthened go-to-market strategy, leadership development, and capital allocation to support scalable growth.

Acquisition of Nagarro and global expansion

• Announced acquisition of Nagarro, a €1B digital engineering firm with 18,003 professionals and strong European presence.

• Transaction valued at EUR ~1.27B (1.27x EV/CY25A Revenue, 9.19x EV/Adj. EBITDA), offering a 140% premium to Nagarro’s undisturbed share price.

• Acquisition creates a globally balanced profile, expanding capabilities in AI, digital, ERP, and CX, and diversifying across regions and verticals.

• Nagarro’s management supports the deal; Persistent has secured a 21% stake and met the minimum acceptance threshold for the public offer.

• Closing expected in Q4 CY26/Q1 CY27, pending final regulatory and shareholder approvals.